Logo image of CONE

CYRUSONE INC (CONE) Stock Fundamental Analysis

NASDAQ:CONE - Nasdaq - REIT

90.36  +0.03 (+0.03%)

After market: 90.48 +0.12 (+0.13%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CONE. CONE was compared to 129 industry peers in the Diversified REITs industry. CONE has a bad profitability rating. Also its financial health evaluation is rather negative. CONE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CONE was profitable.
CONE Yearly Net Income VS EBIT VS OCF VS FCFCONE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 -500M -1B

1.2 Ratios

Industry RankSector Rank
ROA 0.34%
ROE 0.87%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CONE Yearly ROA, ROE, ROICCONE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -2 -4

1.3 Margins

Industry RankSector Rank
OM 4.86%
PM (TTM) 2.1%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CONE Yearly Profit, Operating, Gross MarginsCONE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 40 60

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, CONE has more shares outstanding
The debt/assets ratio for CONE has been reduced compared to a year ago.
CONE Yearly Shares OutstandingCONE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M
CONE Yearly Total Debt VS Total AssetsCONE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2B 4B 6B

2.2 Solvency

CONE has a Debt/Equity ratio of 1.25. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.25
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
CONE Yearly LT Debt VS Equity VS FCFCONE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 1B -1B 2B 3B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

4

3. Growth

3.1 Past

CONE shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.71%.
CONE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.04% yearly.
Looking at the last year, CONE shows a quite strong growth in Revenue. The Revenue has grown by 16.66% in the last year.
Measured over the past years, CONE shows a quite strong growth in Revenue. The Revenue has been growing by 17.91% on average per year.
EPS 1Y (TTM)5.71%
EPS 3Y-38.87%
EPS 5Y9.04%
EPS Q2Q%-26.67%
Revenue 1Y (TTM)16.66%
Revenue growth 3Y13.65%
Revenue growth 5Y17.91%
Sales Q2Q%18.63%

3.2 Future

Based on estimates for the next years, CONE will show a very negative growth in Earnings Per Share. The EPS will decrease by -13.73% on average per year.
The Revenue is expected to grow by 7.04% on average over the next years.
EPS Next Y-51.93%
EPS Next 2Y-20.55%
EPS Next 3Y-16.34%
EPS Next 5Y-13.73%
Revenue Next Year6.44%
Revenue Next 2Y7.57%
Revenue Next 3Y6.87%
Revenue Next 5Y7.04%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CONE Yearly Revenue VS EstimatesCONE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
CONE Yearly EPS VS EstimatesCONE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5 1 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 244.22, which means the current valuation is very expensive for CONE.
When comparing the Price/Earnings ratio of CONE to the average of the S&P500 Index (24.21), we can say CONE is valued expensively.
The Price/Forward Earnings ratio is 508.02, which means the current valuation is very expensive for CONE.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.44, CONE is valued quite expensively.
Industry RankSector Rank
PE 244.22
Fwd PE 508.02
CONE Price Earnings VS Forward Price EarningsCONE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400 500

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 27.17
CONE Per share dataCONE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

A cheap valuation may be justified as CONE's earnings are expected to decrease with -16.34% in the coming years.
PEG (NY)N/A
PEG (5Y)27.01
EPS Next 2Y-20.55%
EPS Next 3Y-16.34%

More info and screens

3

5. Dividend

5.1 Amount

CONE has a Yearly Dividend Yield of 2.30%.
Compared to an average S&P500 Dividend Yield of 2.44, CONE has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.3%

5.2 History

The dividend of CONE has a limited annual growth rate of 4.43%.
CONE has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)4.43%
Div Incr YearsN/A
Div Non Decr YearsN/A
CONE Yearly Dividends per shareCONE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 0.5 1 1.5 2 2.5

5.3 Sustainability

CONE pays out 1003.56% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of CONE has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP1003.56%
EPS Next 2Y-20.55%
EPS Next 3Y-16.34%
CONE Yearly Income VS Free CF VS DividendCONE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 0 200M -200M -400M -600M -800M -1B
CONE Dividend Payout.CONE Dividend Payout, showing the Payout Ratio.CONE Dividend Payout.PayoutRetained Earnings

More info and screens

CYRUSONE INC

NASDAQ:CONE (3/24/2022, 8:00:01 PM)

After market: 90.48 +0.12 (+0.13%)

90.36

+0.03 (+0.03%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-16 2022-02-16/amc
Earnings (Next)04-27 2022-04-27/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners0.75%
Ins Owner Change0%
Market Cap11.85B
Analysts67.27
Price Target91.25 (0.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.3%
Yearly Dividend2.05
Dividend Growth(5Y)4.43%
DP1003.56%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 244.22
Fwd PE 508.02
P/S 9.83
P/FCF N/A
P/OCF N/A
P/B 4.05
P/tB N/A
EV/EBITDA 27.17
EPS(TTM)0.37
EY0.41%
EPS(NY)0.18
Fwd EY0.2%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS9.19
BVpS22.29
TBVpSN/A
PEG (NY)N/A
PEG (5Y)27.01
Profitability
Industry RankSector Rank
ROA 0.34%
ROE 0.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 4.86%
PM (TTM) 2.1%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 1.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.71%
EPS 3Y-38.87%
EPS 5Y9.04%
EPS Q2Q%-26.67%
EPS Next Y-51.93%
EPS Next 2Y-20.55%
EPS Next 3Y-16.34%
EPS Next 5Y-13.73%
Revenue 1Y (TTM)16.66%
Revenue growth 3Y13.65%
Revenue growth 5Y17.91%
Sales Q2Q%18.63%
Revenue Next Year6.44%
Revenue Next 2Y7.57%
Revenue Next 3Y6.87%
Revenue Next 5Y7.04%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A